Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTR vs GSK✓SelectedUSD · GSKVTR vs GSK performance historyLatest closeAs of-0.52%11/20
Stock and ETF performance explorer

VTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+110.4%
GSK return
+53.4%
Excess return
+57.0%
Maximum drawdown
-19.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%-0.1%-0.4%-0.5%
7D-2.7%-5.3%+2.7%-1.4%
30D+1.4%-3.7%+5.0%+2.3%
3M-6.1%-7.3%+1.2%-4.5%
6M-1.2%-4.2%+3.1%-0.2%
YTD+13.9%+0.9%+13.0%+13.5%
1Y+11.2%+7.3%+3.9%+9.2%
3Y+110.4%+52.7%+57.6%+75.2%
All+110.4%+53.4%+57.0%+75.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling